Conference Speakers

Introducing the New Eczema Standard: A Breakthrough in Microbiome-Friendly Product Testing

Eczema and diaper dermatitis are common skin conditions that can significantly disrupt infant health, often linked to imbalances in the skin microbiome. In particular, diaper dermatitis has been associated with an overgrowth of Staphylococcus aureus, a pathogen that can exacerbate skin inflammation. While hygiene and skincare products aim to alleviate symptoms, it is critical that they not only reduce harmful bacteria but also preserve the delicate balance of the skin microbiome.

Recognizing this need, MyMicrobiome has developed a groundbreaking new Eczema Standard—a first-of-its-kind certification designed to rigorously assess the microbiome impact of products intended for eczema-prone skin. This newly established standard represents a major step forward in microbiome-friendly product evaluation, utilizing cutting-edge in vitro testing methods to examine product effects on eight distinct S. aureus strains while ensuring the protection of beneficial skin microbes essential for homeostasis.

One of the most innovative aspects of the new Eczema Standard is its balance test, which uniquely evaluates the interaction between S. aureus and Staphylococcus hominis—a natural skin bacterium known for its antagonistic effects on S. aureus. By incorporating this test, MyMicrobiome provides a scientifically robust and industry-first approach to determining whether products truly support a balanced and healthy skin microbiome.

This presentation will introduce the newly launched Eczema Standard, highlight its unique scientific foundation, and explore its implications for the future of microbiome-friendly skincare and hygiene products. With this innovative certification, brands now have a powerful tool to differentiate their products and ensure microbiome compatibility for sensitive and eczema-prone skin.